Memoril Mite

Piracetam, the active ingredient in Memoril Mite, is a racetam presented as an oral formulation for oral use. It belongs to the cognitive enhancer class and is used to support memory and learning processes in adults, particularly where age‑related cognitive decline is observed.

GNH USA supplies Memoril Mite as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality and regulatory compliance.

Piracetam is a racetam cognitive enhancer that influences neuronal function and is used in several neurological conditions.

Age‑related cognitive decline: may improve memory and attention in older adults. Dyslexia: may support reading skills and language processing in children. Vertigo and balance disorders: may reduce the frequency and severity of vertiginous episodes.

Piracetam is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate intensity. - Insomnia: difficulty initiating or maintaining sleep. - Nausea: occasional gastrointestinal upset. - Anxiety: feelings of nervousness or restlessness. - Dizziness: transient light‑headedness. - Fatigue: reduced energy levels.

Serious or Rare Side Effects: - Skin rash: may indicate hypersensitivity. - Thrombocytopenia: reduced platelet count. - Depression: worsening mood symptoms. - Seizures: rare occurrence in predisposed individuals. - Severe allergic reactions: anaphylaxis or angioedema.

When considering Piracetam therapy, several safety measures should be observed. - Assess renal function: adjust use if significant impairment exists. - Monitor behavioral changes: report agitation, depression, or mood swings. - Avoid in patients with known hypersensitivity: discontinue if rash develops. - Use caution in elderly: initiate at the lowest effective dose. - Store at ambient temperature: keep in the original pack, protect from moisture.

Piracetam may interact with other medicines; awareness of potential interactions is important.

Major Interactions (Avoid): - Anticoagulants: may increase bleeding risk. - Anticonvulsants: may reduce seizure‑control efficacy.

Moderate Interactions (Monitor Closely): - Caffeine: may heighten nervousness or insomnia. - Alcohol: may enhance sedative effects. - Other racetams: may produce additive central nervous system effects.